Immuneering Corp SEC filings IMRX

Immuneering Corp has 322 filings in SEC EDGAR's recent list, going back to Oct 4, 2019. Its latest annual report, Form 10-K, was filed on Mar 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Immuneering Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 28, 2026 —
4 Insider transaction Jul 17, 2026 Jul 16, 2026
3 Initial insider ownership Jul 16, 2026 Jul 16, 2026
4 Insider transaction Jun 24, 2026 Jun 23, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
8-K Current report
Officer or director change
Jun 15, 2026 Jun 11, 2026
4 Insider transaction Jun 11, 2026 Jun 11, 2026
4 Insider transaction Jun 11, 2026 Jun 11, 2026
4 Insider transaction Jun 11, 2026 Jun 11, 2026
4 Insider transaction Jun 11, 2026 Jun 11, 2026
4 Insider transaction Jun 11, 2026 Jun 11, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 11, 2026
8-K Current report
Other events
Jun 1, 2026 Jun 1, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
DEFA14A Additional proxy material Apr 20, 2026 —
DEF 14A Proxy statement Apr 20, 2026 Apr 20, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
10-K Annual report Mar 6, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 6, 2026 Mar 6, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 22, 2026 —
4 Insider transaction Jan 21, 2026 Jan 16, 2026
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 16, 2026 Jan 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 15, 2026 —
4 Insider transaction Jan 15, 2026 Jan 13, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
8-K Current report
Other events
Jan 7, 2026 Jan 7, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 21, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2025 —
4 Insider transaction Oct 7, 2025 Oct 3, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 3, 2025 —
4 Insider transaction Oct 2, 2025 Oct 1, 2025
4 Insider transaction Oct 2, 2025 Oct 1, 2025
4 Insider transaction Oct 2, 2025 Oct 1, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Sep 30, 2025 Sep 29, 2025
424B5 Prospectus supplement Sep 25, 2025 —
8-K Current report
Material agreement, Other events
Sep 25, 2025 Sep 24, 2025
FWP Free writing prospectus Sep 25, 2025 —
FWP Free writing prospectus Sep 24, 2025 —
424B5 Prospectus supplement Sep 24, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 24, 2025 Sep 24, 2025
144 Notice of proposed sale Sep 23, 2025 —
4 Insider transaction Sep 17, 2025 Sep 15, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
D Filing Sep 9, 2025 —
EFFECT Filing Sep 8, 2025 —
424B3 Prospectus Sep 8, 2025 —
CORRESP Letter to the SEC Sep 4, 2025 —
UPLOAD Letter from the SEC Sep 4, 2025 —
S-3 Shelf registration Sep 3, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 25, 2025 Aug 21, 2025
EFFECT Filing Aug 20, 2025 —
CORRESP Letter to the SEC Aug 18, 2025 —
UPLOAD Letter from the SEC Aug 18, 2025 —
S-3 Shelf registration Aug 13, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jun 30, 2025 Jun 27, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
424B5 Prospectus supplement Jun 23, 2025 —
4 Insider transaction Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
8-K Current report
Other events
Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 16, 2025 Jun 13, 2025
8-K Current report
Shareholder vote results
Jun 16, 2025 Jun 13, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
S-8 Employee stock plan registration May 5, 2025 —
DEFA14A Additional proxy material Apr 21, 2025 —
DEF 14A Proxy statement Apr 21, 2025 Apr 21, 2025
4 Insider transaction Mar 24, 2025 Mar 21, 2025
3 Initial insider ownership Mar 24, 2025 Mar 17, 2025
424B5 Prospectus supplement Mar 20, 2025 —
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 17, 2025 —
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Jan 7, 2025 Jan 7, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
4 Insider transaction Jan 2, 2025 Jan 1, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K/A Amended current report
Officer or director change
Oct 2, 2024 Mar 11, 2024
4 Insider transaction Sep 17, 2024 Sep 15, 2024
8-K Current report
Other events
Sep 12, 2024 Sep 12, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
4 Insider transaction Jun 13, 2024 Jun 12, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 12, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
4 Insider transaction May 23, 2024 May 21, 2024
8-K Current report
Officer or director change
May 23, 2024 May 21, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Apr 23, 2024
SC 13G/A Amended ownership over 5% (passive) Apr 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Apr 10, 2024 —
SC 13G/A Amended ownership over 5% (passive) Apr 5, 2024 —
4 Insider transaction Apr 3, 2024 Apr 1, 2024
SC 13G/A Amended ownership over 5% (passive) Mar 27, 2024 —
4 Insider transaction Mar 25, 2024 Mar 22, 2024
4 Insider transaction Mar 25, 2024 Mar 22, 2024
4 Insider transaction Mar 25, 2024 Mar 22, 2024
4 Insider transaction Mar 25, 2024 Mar 15, 2024
4 Insider transaction Mar 21, 2024 Mar 15, 2024
4 Insider transaction Mar 21, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 18, 2024
4 Insider transaction Mar 19, 2024 Mar 18, 2024
4 Insider transaction Mar 19, 2024 Mar 19, 2024
4 Insider transaction Mar 18, 2024 Mar 14, 2024
8-K Current report
Officer or director change, Other events
Mar 14, 2024 Mar 11, 2024
4 Insider transaction Mar 12, 2024 Mar 11, 2024
3 Initial insider ownership Mar 12, 2024 Mar 11, 2024
10-K Annual report Mar 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 1, 2024 Mar 1, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
8-K Current report
Bylaw or fiscal year change
Feb 2, 2024 Feb 1, 2024
SC 13G Ownership over 5% (passive) Jan 26, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 16, 2024 —
4 Insider transaction Jan 2, 2024 Jan 1, 2024
4 Insider transaction Jan 2, 2024 Jan 1, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
8-K Current report
Shareholder vote results
Jun 15, 2023 Jun 14, 2023
4 Insider transaction Jun 14, 2023 Jun 13, 2023
8-K Current report
Officer or director change
Jun 14, 2023 Jun 13, 2023
SC 13G/A Amended ownership over 5% (passive) May 5, 2023 —
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report May 4, 2023 May 4, 2023
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 May 1, 2023
SC 13G/A Amended ownership over 5% (passive) Apr 24, 2023 —
3 Initial insider ownership Apr 24, 2023 Apr 20, 2023
8-K Current report
Material agreement
Apr 19, 2023 Apr 18, 2023
424B5 Prospectus supplement Apr 19, 2023 —
424B5 Prospectus supplement Apr 18, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Apr 18, 2023 Apr 18, 2023
4 Insider transaction Apr 3, 2023 Mar 31, 2023
3 Initial insider ownership Apr 3, 2023 Mar 27, 2023
10-K Annual report Mar 6, 2023 Dec 31, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1790340

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.